Gene · 4929
Papers4,115
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 4,115
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti-Leukemia Efficacy of CAR-T Cells via SOCE-Calcineurin-NFAT and Glycolysis Pathways. | Adv Sci (Weinh) | 2022 | 35032108 | PubTator, text mining | PubMed |
| Single-cell transcriptomics of human iPSC differentiation dynamics reveal a core molecular network of Parkinson's disease. | Commun Biol | 2022 | 35027645 | PubTator, text mining | PubMed |
| (Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders. | Lipids Health Dis | 2022 | 35027074 | PubTator, text mining | PubMed |
| Structural Aspects of LIMK Regulation and Pharmacology. | Cells | 2022 | 35011704 | PubTator, text mining | PubMed |
| Transcriptomics and network analysis highlight potential pathways in the pathogenesis of pterygium. | Sci Rep | 2022 | 34997134 | PubTator, text mining | PubMed |
| Evaluation of animal model congruence to human depression based on large-scale gene expression patterns of the CNS. | Sci Rep | 2022 | 34997033 | PubTator, text mining | PubMed |
| Neurogenetic disorders across the lifespan: from aberrant development to degeneration. | Nat Rev Neurol | 2022 | 34987232 | PubTator, text mining | PubMed |
| Mechanism of miR-132-3p Promoting Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson's Disease. | eNeuro | 2022 | 34983831 | PubTator, text mining | PubMed |
| Making neurons, made easy: The use of Neurogenin-2 in neuronal differentiation. | Stem Cell Reports | 2022 | 34971564 | PubTator, text mining | PubMed |
| Systematic characterization of the tumor microenvironment in Chinese patients with hepatocellular carcinoma highlights intratumoral B cells as a potential immunotherapy target. | Oncol Rep | 2022 | 34958112 | PubTator, text mining | PubMed |
| Cryopreservation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurospheres for Clinical Application. | J Parkinsons Dis | 2022 | 34958047 | PubTator, text mining | PubMed |
| Clinical tools and biomarkers to predict preeclampsia. | EBioMedicine | 2022 | 34954654 | PubTator, text mining | PubMed |
| Autonomic behavioral impairment induced by simazine exposure during early life of male mouse is mediated by Lmx1a/Wnt1 pathway. | Environ Toxicol | 2022 | 34936186 | PubTator, text mining | PubMed |
| Is activation of GDNF/RET signaling the answer for successful treatment of Parkinson's disease? A discussion of data from the culture dish to the clinic. | Neural Regen Res | 2022 | 34916419 | PubTator, text mining | PubMed |
| Microcystin-leucine arginine exposure induced intestinal lipid accumulation and MC-LR efflux disorder in Lithobates catesbeianus tadpoles. | Toxicology | 2022 | 34863901 | PubTator, text mining | PubMed |
| Role of type-2 innate lymphoid cells (ILC2s) in type-2 asthma. | Curr Opin Allergy Clin Immunol | 2022 | 34840275 | PubTator, text mining | PubMed |
| NR4A2 alleviates cardiomyocyte loss and myocardial injury in rats by transcriptionally suppressing CCR5 and inducing M2 polarization of macrophages. | Microvasc Res | 2022 | 34774582 | PubTator, text mining | PubMed |
| Systematic Pan-Cancer Characterization of Nuclear Receptors Identifies Potential Cancer Biomarkers and Therapeutic Targets. | Cancer Res | 2022 | 34750098 | PubTator, text mining | PubMed |
| Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells. | Mol Carcinog | 2022 | 34699643 | PubTator, text mining | PubMed |
| The dopamine transporter gene SLC6A3: multidisease risks. | Mol Psychiatry | 2022 | 34650206 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4929/papers?page=49